Skip to main content

CareTrust REIT, Inc.

For the period ended Mar 31, 2026. Filed May 7, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

CTRE$38.84-0.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

(in thousands)

For the Three Months Ended March 31,
20262025
Cash flows from operating activities:
Net income$79,505$65,193
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (including below-market ground leases)29,47217,865
Amortization of deferred financing costs1,120914
Unrealized gain on other real estate related investments, net(7)(1,287)
Amortization of stock-based compensation3,4483,909
Straight-line rental income(3,843)7
Amortization of lease incentives4949
Amortization of above and below market leases1(926)
Noncash interest income(2,082)(1,904)
Gain on sale of real estate, net—(3,876)
Change in operating assets and liabilities:
Accounts and other receivables(512)(788)
Prepaid expenses and other assets, net(1,486)(3,451)
Accounts payable, accrued liabilities and deferred rent liabilities(15,300)(4,323)
Net cash provided by operating activities90,36571,382
Cash flows from investing activities:
Acquisitions of real estate, net of deposits applied(71,727)(40,162)
Purchases of equipment, furniture and fixtures and improvements to real estate(3,160)(2,276)
Investment in real estate related investments and other loans receivable(30,549)(6,389)
Principal payments received on real estate related investments and other loans receivable3404,582
Escrow deposits for potential acquisitions of real estate(153)(36,066)
Net proceeds from sales of real estate—44,401
Net cash used in investing activities(105,249)(35,910)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net127,90415,562
Borrowings under unsecured revolving credit facility—425,000
Payments on deferred financing costs—(141)
Net-settle adjustment on restricted stock(10,490)(3,325)
Dividends paid on common stock(74,805)(54,388)
Contributions from noncontrolling interests1251,410
Distributions to noncontrolling interests(2,204)(902)
Net cash provided by financing activities40,530383,216
Effect of foreign currency translation on cash and cash equivalents(481)—
Net increase in cash and cash equivalents25,165418,688
Cash and cash equivalents as of the beginning of period198,042213,822
Cash and cash equivalents as of the end of period$223,207$632,510
Supplemental disclosures of cash flow information:
Interest paid$6,238$450
Supplemental schedule of noncash investing and financing activities:
Increase in dividends and distributions payable$13,741$8,665
Accrued costs payable related to acquisitions of real estate$487$—
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.